Lap-Band maker targets teenagers
With sales of its Lap-Band weight-loss device declining, Allergan Inc. has its eyes on a new set of potential customers -- overweight teenagers. The Irvine company has asked the Food and Drug Administration to approve Lap-Band surgeries for adolescents as young as 14, and is conducting clinical trials on teenage patients, said Cathy Taylor, a company spokeswoman. Allergan says the device -- a silicon ring fitted around the stomach to reduce food intake -- has proved a safe and effective way for obese adults to shed pounds. With an estimated one-third of U.S. children now overweight, the benefits should be extended to teenagers, Taylor said. "We identified a significant need with this patient population in terms of the increasing rate of obesity in younger populations," Taylor said. "Obesity, if left untreated, correlates to life-threatening diseases." But many doctors and health experts are concerned that there are not enough data about the Lap-Band's long-term safety and effectiveness, something that would be particularly relevant when considering the device for children.
- Governors Push to Expand Role of PAs, Telemedicine
- Why Open Payments Irks Physicians
- 3 More Pioneer ACOs Say They Will Quit
- Top Provider Billing Mistakes Are Changing
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- Overcoming a Payer Mix 'Nightmare'
- Telemetry Overuse Cost Health System $4.8 Million in One Year
- Employee Engagement: Make It Meaningful
- Difficult Patients: It's Not Them, It's You, Doctor
- Driving Down Claims Denials